Hims & Hers Health, Inc. 8-K

What Happened

• Hims & Hers Health, Inc. (HIMS) filed an 8‑K on June 2, 2026 disclosing Amendment No. 3 (dated May 29, 2026) to its Revolving Credit and Guaranty Agreement with lenders led by JPMorgan Chase Bank, N.A. The amendment was made to facilitate the company’s acquisition of EUC Management Pty Ltd (d/b/a Eucalyptus).
• The Amendment provides a grace period for the company to comply with certain covenants and representations and warranties that could be affected by the Eucalyptus acquisition, and sets other changes to accommodate the transaction.

Key Details

• Amendment date: May 29, 2026; 8‑K filed: June 2, 2026.
• Acquisition target: EUC Management Pty Ltd ACN 631 013 860 (d/b/a Eucalyptus).
• Material changes in the Amendment:
  • Grace period for covenant and representation/warranty compliance related to the acquisition.
  • Joinder obligations established for material foreign subsidiaries.
  • Increased downstream investment capacity in non‑loan party subsidiaries.
• Other loan terms: loans and obligations otherwise remain unchanged; no material changes to interest provisions, fees, covenants or events of default per the filing.

Why It Matters

• The amendment reduces near‑term covenant risk tied to the Eucalyptus acquisition by giving Hims & Hers temporary relief to meet credit agreement requirements, lowering the chance of a technical default as the deal closes and integration begins.
• It also clarifies lender rights and expands flexibility for investments through subsidiaries, which can affect how the company funds and manages its international operations post‑acquisition.
• Importantly, the filing states the amendment does not materially change interest rates, fees, covenants, or events of default, indicating the company’s overall borrowing cost and default triggers remain intact.